🇺🇸 FDA
Patent

US 8663936

Sodium channel protein type III α-subunit splice variant

granted A61PA61P1/00A61P11/06

Quick answer

US patent 8663936 (Sodium channel protein type III α-subunit splice variant) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/00, A61P11/06, A61P25/00, A61P25/18